Researchclopedia
Research
Researchers
Institutions
Topics
Submit
About
Search...
⌘
K
Command Palette
Search for a command to run...
Back to research
Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial
2012
539 citations
Journal Article
green Open Access
Field-Weighted Citation Impact:
31.67
Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial | Researchclopedia
·
GlaxoSmithKline (United States)
Christopher Moy
·
GlaxoSmithKline (United States)
Stephen A. Szabo
·
GlaxoSmithKline (United States)
Lori Roadcap
·
GlaxoSmithKline (United States)
Vijay Peddareddigari
·
GlaxoSmithKline (United States)
Peter F. Lebowitz
·
GlaxoSmithKline (United States)
Ngocdiep T. Le
·
GlaxoSmithKline (United States)
Howard A. Burris
·
Tennessee Oncology
Wells A. Messersmith
·
University of Colorado Denver
Peter J. O’Dwyer
·
University of Pennsylvania
Kevin B. Kim
·
The University of Texas MD Anderson Cancer Center
Keith T. Flaherty
·
University of Pennsylvania
Johanna C. Bendell
·
Tennessee Oncology
René González
·
University of Colorado Denver
Razelle Kurzrock
·
The University of Texas MD Anderson Cancer Center
Leslie A. Fecher
·
University of Pennsylvania